Hospital
Erlanger Health
Erlanger Health was paid $3.27M by Medicaid between Jul 2023 and Dec 2024, across 75 billing codes. Its largest line is 99283, emergency room visit (moderate) — 25% of everything it billed.
33Billing provider infoERLANGER HEALTH
CHATTANOOGA, TN 37403
CHATTANOOGA, TN 37403
33aNPI1861194086assigned 03/21/2023
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.27M
24GClaims43,354
24DCodes billed75
24AFirst – last monthJul 2023 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Tennessee
Rank by total paid#54 of 71
Median peer was paid$6.96M
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 14,670 | $1.22M | |
| 2024incomplete | 28,684 | $2.04M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 25% | 11,949 | 10,880 | $823K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 5,572 | 5,108 | $750K |
| 41899 | Unlisted procedure, dentoalveolar structures | 9.9% | 666 | 622 | $323K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 7.1% | 1,126 | 991 | $232K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.6% | 1,070 | 888 | $216K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 6.3% | 400 | 375 | $207K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.1% | 1,447 | 1,287 | $133K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.0% | 1,200 | 1,084 | $97K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 3,909 | 3,239 | $65K |
| 93325 | 1.7% | 369 | 347 | $55K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1.0% | 37 | 37 | $34K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 35 | 34 | $32K |
63 more codes
| 76770 | <1% | 150 | $29K | |
| 80053 | Comprehensive metabolic panel | <1% | 1,639 | $28K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 725 | $25K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 583 | $25K |
| 93321 | <1% | 182 | $23K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 386 | $22K |
| 87634 | <1% | 86 | $15K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 786 | $14K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 14 | $13K |
| 93304 | <1% | 53 | $11K | |
| G0378 | Hospital observation service, per hour | <1% | 29 | $11K |
| 80047 | <1% | 496 | $10K | |
| 59025 | Fetal non-stress test | <1% | 1,196 | $9K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 347 | $8K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 141 | $6K |
| 87076 | <1% | 57 | $5K | |
| 81001 | <1% | 1,465 | $4K | |
| 86141 | <1% | 69 | $3K | |
| 84702 | <1% | 64 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 56 | $3K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 74 | $2K |
| 81003 | <1% | 870 | $2K | |
| 85027 | <1% | 56 | $2K | |
| 83690 | <1% | 170 | $2K | |
| 74019 | <1% | 48 | $2K | |
| 95812 | <1% | 13 | $2K | |
| 80076 | <1% | 216 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 124 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 173 | $1K |
| 86900 | <1% | 124 | $1K | |
| 86901 | <1% | 124 | $1K | |
| 85007 | <1% | 56 | $1K | |
| 83615 | <1% | 148 | $1K | |
| 82570 | <1% | 141 | $992.78 | |
| 85384 | <1% | 62 | $916.42 | |
| 81025 | <1% | 95 | $914.94 | |
| 72081 | <1% | 12 | $831.51 | |
| 84550 | <1% | 146 | $804.39 | |
| 85730 | <1% | 53 | $789.45 | |
| 74018 | <1% | 15 | $779.68 | |
| 72170 | <1% | 12 | $670.71 | |
| L8699 | Prosthetic implant, not otherwise specified | <1% | 37 | $570.38 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 776 | $556.14 |
| 94010 | <1% | 12 | $526.26 | |
| 85610 | <1% | 52 | $518.04 | |
| 84156 | <1% | 145 | $417.18 | |
| 83605 | <1% | 13 | $389.52 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 542 | $366.19 |
| 86850 | <1% | 16 | $356.48 | |
| 83735 | <1% | 19 | $202.44 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 52 | $74.79 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 891 | $73.57 |
| 36415 | Collection of venous blood by venipuncture | <1% | 19 | $51.50 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 12 | $14.13 |
| 85014 | 0% | 34 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 14 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 90 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 24 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 909 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 184 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 426 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 17 | $0.00 |
| 85018 | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDEJACO, LYNN (CFO, EXECUTIVE V.P)
| Provider | Location | Paid |
|---|---|---|
| Erlanger Health | Chattanooga, TN | $2.28M |
| Erlanger Health | Pikeville, TN | $281K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.